1. A risk-benefit assessment of iron-chelation therapy;Porter;Drug Saf,1997
2. Transfusional haemosiderosis and chelation therapy;Ley;Clin Haematol,1982
3. Iron overload;Jacobs;Semin Hematol,1977
4. Physicians Desk Reference, 5th ed. Montvale, NJ: Medical Economics, 2000;2012–3.
5. USPDI. Vol. I. Drug. Information for the Health Care Professional. Rockville, MD: United States Pharmacopeial Convention, 1997;1145–8.